Corporate PresentationDownload January 2024 Presentation Select HighlightsDecember 7, 2023STAT6 Program Highlighted in Sanofi R&D DayAccess Webcast »November 29, 2023 | 3:10 p.m. ETPiper Sandler 35th Annual Healthcare ConferenceAccess Webcast »October 31, 20237th Annual Dermatology Drug Development SummitView Presentation »October 17, 2023International Conference of the Inflammation Research Association (IRA)View Presentation » Latest Press ReleasesFebruary 28, 2024Recludix Pharma to Participate in Two Investor Conferences in MarchRead More »February 6, 2024Recludix Pharma to Present at Two Investor Conferences in FebruaryRead More »November 9, 2023Recludix Pharma to Present at Two Investor Conferences in NovemberRead More »October 31, 2023Recludix Pharma Presents Preclinical Data Demonstrating Strong Efficacy and Favorable Safety Profile of REX-7117 Versus TYK2 and JAK Inhibitors at the Dermatology Drug Development SummitRead More » More Press Releases Events and PresentationsFebruary 28, 2024 | 3:25 p.m. ET Evercore ISI 2024 Emerging Biotech ConferenceAccess Webcast »February 13, 2024 | 11:20 a.m. ET Oppenheimer 34th Annual Healthcare Life Sciences ConferenceAccess Webcast »December 7, 2023STAT6 Program Highlighted in Sanofi R&D DayAccess Webcast »November 29, 2023 | 3:10 p.m. ETPiper Sandler 35th Annual Healthcare ConferenceAccess Webcast » More Events and Presentations News Coverage HighlightsAugust 7, 2023BioCentury: Recludix: targeting STATs via their SH2 domainsRead More »July 20, 2023BioWorld: Recludix enters a potential $1.2B deal with SanofiRead More »July 20, 2023SCRIP: Sanofi Adds To Immunology Pipeline In Collaboration With Recludix Read More »July 20, 2023Fierce Biotech: Sanofi pays $125M to go after undruggable inflammatory target with Recludix’s preclinical programRead More »July 20, 2023Endpoints News: Following Dupixent’s rise, Sanofi heads downstream in immunology for $125M small molecule pact with RecludixRead More »